These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 14637183

  • 1. Nadroparine inhibits the hypersensitivity response in the conjunctiva.
    Giannoulaki V, Papathanassiou M, Sitaras NM, Tiligada E.
    Eur J Pharmacol; 2003 Nov 14; 481(1):119-24. PubMed ID: 14637183
    [Abstract] [Full Text] [Related]

  • 2. Changes in histamine content following pharmacologically-induced mast cell degranulation in the rat conjunctiva.
    Tiligada E, Aslanis D, Delitheos A, Varonos D.
    Pharmacol Res; 2000 Jun 14; 41(6):667-70. PubMed ID: 10816337
    [Abstract] [Full Text] [Related]

  • 3. Effect of aminoguanidine on the conjunctival histamine and nitrite levels in experimental conjunctivitis.
    Papathanassiou M, Giannoulaki V, Zampeli E, Tiligada E.
    J Ocul Pharmacol Ther; 2011 Apr 14; 27(2):137-42. PubMed ID: 21500983
    [Abstract] [Full Text] [Related]

  • 4. Leukotriene antagonists attenuate late phase nitric oxide production during the hypersensitivity response in the conjunctiva.
    Papathanassiou M, Giannoulaki V, Tiligada E.
    Inflamm Res; 2004 Aug 14; 53(8):373-6. PubMed ID: 15316668
    [Abstract] [Full Text] [Related]

  • 5. The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva.
    Zampeli E, Thurmond RL, Tiligada E.
    Inflamm Res; 2009 Jun 14; 58(6):285-91. PubMed ID: 19184344
    [Abstract] [Full Text] [Related]

  • 6. Determination of the interval during which one application of compound 48/80 to the rat conjunctiva influences the response to a second application.
    Allansmith MR, Baird RS, Barney NP, Ross RN, Bloch KJ.
    Ophthalmic Res; 1990 Jun 14; 22(3):137-43. PubMed ID: 1696708
    [Abstract] [Full Text] [Related]

  • 7. Heparin inhibits the effects of compound 48/80 and fluoxetine on conjunctival histamine content in vivo.
    Tiligada E, Giannoulaki V, Sitaras N, Varonos D.
    Inflamm Res; 2002 Apr 14; 51 Suppl 1():S07-8. PubMed ID: 12013386
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of fluoxetine on histamine content in the rat conjunctiva].
    Aslanis D, Tiligada E.
    J Fr Ophtalmol; 2001 Feb 14; 24(2):169-71. PubMed ID: 11240489
    [Abstract] [Full Text] [Related]

  • 9. Histamine and fluoxetine: common playground in the rat conjunctiva?
    Tiligada E, Giannoulaki V, Papathanassiou M, Karabela S, Sitaras N, Varonos D.
    Inflamm Res; 2004 Mar 14; 53 Suppl 1():S41-2. PubMed ID: 15054610
    [No Abstract] [Full Text] [Related]

  • 10. Response of rat conjunctival mast cells to multiple versus single applications of compound 48/80.
    Allansmith MR, Baird RS, Barney NP, Ross RN, Bloch KJ.
    Ophthalmic Res; 1989 Mar 14; 21(5):392-400. PubMed ID: 2481251
    [Abstract] [Full Text] [Related]

  • 11. Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats.
    Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM, Spellman JM.
    Int Arch Allergy Immunol; 1993 Mar 14; 101(1):102-6. PubMed ID: 7684628
    [Abstract] [Full Text] [Related]

  • 12. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Mar 14; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamics of Amlexanox (AA-673) in normal and anaphylactic rat conjunctiva and its effect on histamine concentration.
    Rankov G, Sasaki K, Fukuda M.
    Ophthalmic Res; 1990 Mar 14; 22(6):359-64. PubMed ID: 2089346
    [Abstract] [Full Text] [Related]

  • 14. Anti-allergic activity of German chamomile (Matricaria recutita L.) in mast cell mediated allergy model.
    Chandrashekhar VM, Halagali KS, Nidavani RB, Shalavadi MH, Biradar BS, Biswas D, Muchchandi IS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):336-40. PubMed ID: 21651969
    [Abstract] [Full Text] [Related]

  • 15. Histamine release into tracheal lumen and bronchial reactivity. Effect of compound 48/80 administered by different routes in various doses on histamine release and bronchial reactivity.
    Zimmerman I, Ulmer WT, Park SH.
    Res Exp Med (Berl); 1983 Sep 01; 183(1):55-65. PubMed ID: 6195701
    [Abstract] [Full Text] [Related]

  • 16. Role of mast cell histamine in the formation of rat paw edema: a microdialysis study.
    Guo Y, Mochizuki T, Morii E, Kitamura Y, Maeyama K.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):237-43. PubMed ID: 9274985
    [Abstract] [Full Text] [Related]

  • 17. Dual effect of verapamil on rat peritoneal mast cells: inhibition or induction of histamine release.
    Lunardi LO, Vugman I.
    Braz J Med Biol Res; 1982 Oct 23; 15(4-5):269-73. PubMed ID: 6189538
    [Abstract] [Full Text] [Related]

  • 18. Conjunctival immediate hypersensitivity: re-evaluation of histamine involvement in the vasopermeability response.
    Woodward DF, Ledgard SE, Nieves AL.
    Invest Ophthalmol Vis Sci; 1986 Jan 23; 27(1):57-63. PubMed ID: 2934347
    [Abstract] [Full Text] [Related]

  • 19. Activated T cells in an animal model of allergic conjunctivitis.
    Carreras I, Carreras B, McGrath L, Rice A, Easty DL.
    Br J Ophthalmol; 1993 Aug 23; 77(8):509-14. PubMed ID: 8025049
    [Abstract] [Full Text] [Related]

  • 20. The histamine releasers crotamine, protamine and compound 48/80 activate specific proteases and phospholipases A2.
    Mancin AC, Soares AM, Giglio CA, Andrião-Escarso SH, Vieira CA, Giglio JR.
    Biochem Mol Biol Int; 1997 Sep 23; 42(6):1171-7. PubMed ID: 9305535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.